KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 52 filers reported holding KEROS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,641,262 | -5.0% | 176,953 | +19.7% | 0.00% | 0.0% |
| Q2 2023 | $5,938,001 | +4.7% | 147,785 | +11.3% | 0.00% | 0.0% |
| Q1 2023 | $5,669,194 | -11.5% | 132,768 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $6,403,563 | +39.4% | 133,352 | +9.2% | 0.00% | 0.0% |
| Q3 2022 | $4,595,000 | +62.7% | 122,116 | +19.5% | 0.00% | +100.0% |
| Q2 2022 | $2,824,000 | -48.5% | 102,175 | +1.4% | 0.00% | -50.0% |
| Q1 2022 | $5,479,000 | -4.8% | 100,740 | +2.4% | 0.00% | 0.0% |
| Q4 2021 | $5,754,000 | +47.6% | 98,336 | -0.2% | 0.00% | +100.0% |
| Q3 2021 | $3,899,000 | +16.8% | 98,544 | +25.4% | 0.00% | 0.0% |
| Q2 2021 | $3,338,000 | -7.0% | 78,584 | +34.8% | 0.00% | 0.0% |
| Q1 2021 | $3,589,000 | -8.7% | 58,310 | +4.6% | 0.00% | -50.0% |
| Q4 2020 | $3,932,000 | +132.4% | 55,733 | +27.1% | 0.00% | +100.0% |
| Q3 2020 | $1,692,000 | +3.9% | 43,849 | +1.0% | 0.00% | 0.0% |
| Q2 2020 | $1,629,000 | – | 43,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |